Star Combo Pharma Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	27.81	26.02	24.7	22.88	26.72
Other Revenue	-	-	-	0.08	0.24
Revenue	27.81	26.02	24.7	22.96	26.97
Revenue Growth (YoY)	6.89%	5.34%	7.57%	-14.86%	-31.00%
Cost of Revenue	21.54	20.3	19.91	18.79	23.54
Gross Profit	6.27	5.71	4.79	4.17	3.43
Selling, General & Admin	6.51	4.84	3.79	4.54	5.09
Other Operating Expenses	-5.24	-0.2	-0.16	-0.3	-
Operating Expenses	1.27	4.79	3.66	4.24	5.41
Operating Income	5	0.92	1.12	-0.06	-1.98
Interest Expense	-0.19	-0.2	-0.19	-0.17	-0.24
Interest & Investment Income	0.43	0.26	0.13	0.05	0.11
Currency Exchange Gain (Loss)	0.08	0.01	-0.05	0.05	-0.05
Other Non Operating Income (Expenses)	-0	0	-	0	-
EBT Excluding Unusual Items	5.31	1	1.02	-0.14	-2.16
Impairment of Goodwill	-	-	-	-	-6.34
Gain (Loss) on Sale of Assets	-	-	-	-0.09	-
Asset Writedown	-	-	-4.41	-1.46	-
Legal Settlements	-	-	-0.06	-	-
Other Unusual Items	-	-	-	0.6	1.04
Pretax Income	5.31	1	-3.45	-1.08	-7.46
Income Tax Expense	0.06	0.25	0.55	-0.39	0.41
Net Income	5.25	0.75	-4	-0.7	-7.88
Preferred Dividends & Other Adjustments	1.27	-	-	-	-
Net Income to Common	3.98	0.75	-4	-0.7	-7.88
Net Income Growth	602.32%	-	-	-	-
Shares Outstanding (Basic)	135	135	135	135	135
Shares Outstanding (Diluted)	135	135	135	135	135
Shares Change (YoY)	-	-	0.37%	-0.15%	47.45%
EPS (Basic)	0.03	0.01	-0.03	-0.01	-0.06
EPS (Diluted)	0.03	0.01	-0.03	-0.01	-0.06
EPS Growth	432.75%	-	-	-	-
Free Cash Flow	11.55	-1.76	-0.85	-6.76	-6.93
Free Cash Flow Per Share	0.09	-0.01	-0.01	-0.05	-0.05
Dividend Per Share	0.004	0.004	-	-	-
Gross Margin	22.55%	21.96%	19.38%	18.18%	12.72%
Operating Margin	17.98%	3.55%	4.55%	-0.28%	-7.34%
Profit Margin	14.31%	2.87%	-16.21%	-3.03%	-29.20%
Free Cash Flow Margin	41.52%	-6.76%	-3.44%	-29.45%	-25.68%
EBITDA	6.64	1.73	1.63	0.37	-1.54
EBITDA Margin	23.86%	6.65%	6.59%	1.59%	-5.70%
D&A For EBITDA	1.64	0.81	0.51	0.43	0.44
EBIT	5	0.92	1.12	-0.06	-1.98
EBIT Margin	17.98%	3.55%	4.55%	-0.28%	-7.34%
Effective Tax Rate	1.20%	25.35%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.